Total Voting Rights

Summary by AI BETAClose X

Hemogenyx Pharmaceuticals announced on September 30, 2025, that its total issued share capital consists of 5,361,267 ordinary shares with a nominal value of 1p each. The company confirms that none of these shares are held in treasury. Therefore, the total number of voting rights attached to the company's shares is 5,361,267. This figure can be used by shareholders to calculate their notification requirements regarding their investment in the company's share capital, according to the Financial Conduct Authority's rules.

Disclaimer*

UK 100

Latest directors dealings